美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Avalyn Pharma

31.62

+0.10000.32%

盘前：32.040.4200+1.33%05:54 EDT

成交量：17.73万

成交额：563.06万

市值：14.02亿

市盈率：-13.57

高：33.00

开：31.34

低：30.97

收：31.52

52周最高：40.17

52周最低：24.15

股本：4,433.31万

流通股本：1,666.67万

量比：0.46

换手率：1.06%

股息：- -

股息率：- -

每股收益(TTM):-2.3300

每股收益(LYR):-87.7434

净资产收益率：-68.34%

总资产收益率：-41.74%

市净率：3.52

市盈率(LYR):-0.36

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

新闻稿：Avalyn任命Robert J. Meyer医学博士为董事会成员

Avalyn完成AP01（吸入性吡非尼酮）针对进展性肺纤维化患者的2b期Mist试验目标入组

Avalyn Pharma 将公布AP01（吸入性吡非尼酮）治疗肺纤维化的更多长期数据

异动解读 | Avalyn Pharma IPO首日盘中大涨44.44%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/AVLN"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","market":"US","secType":"STK","nameCN":"Avalyn Pharma","latestPrice":31.62,"timestamp":1790020800000,"preClose":31.52,"halted":0,"volume":177307,"hourTrading":{"tag":"盘前","latestPrice":32.04,"preClose":31.62,"latestTime":"05:54 EDT","volume":1,"amount":32.04,"timestamp":1790070848077,"change":0.42,"changeRate":0.013283,"amplitude":0},"delay":0,"changeRate":0.0031725888324873547,"floatShares":16666700,"shares":44333095,"eps":-2.33,"marketStatus":"盘前交易","change":0.1,"latestTime":"09-22 05:54:55 EDT","open":31.34,"high":33,"low":30.97,"amount":5630636.624782001,"amplitude":0.064404,"askPrice":33.65,"askSize":89,"bidPrice":12.78,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.33,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790083800000},"marketStatusCode":1,"adr":0,"listingDate":1777521600000,"exchange":"NASDAQ","adjPreClose":31.62,"preHourTrading":{"tag":"盘前","latestPrice":32.04,"preClose":31.62,"latestTime":"05:54 EDT","volume":1,"amount":32.04,"timestamp":1790070848077,"change":0.42,"changeRate":0.013283,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":31.62,"preClose":31.62,"latestTime":"19:30 EDT","volume":1020,"amount":32252.4,"timestamp":1790033402831,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.45520151814428866,"impliedVol":0.6718,"impliedVolPercentile":0.8095},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","floatShares":16666700,"roa":"-41.74%","roe":"-68.34%","lyrEps":-87.743381,"volumeRatio":0.45520151814428866,"shares":44333095,"dividePrice":0,"high":33,"amplitude":0.064404,"preClose":31.52,"low":30.97,"week52Low":24.15,"pbRate":"3.52","week52High":40.17,"institutionHeld":0,"latestPrice":31.62,"committee":0.058201,"eps":-2.33,"divideRate":0,"volume":177307,"delay":0,"ttmEps":-2.33,"open":31.34,"prevYearClose":18,"prevWeekClose":31.52,"prevMonthClose":34.73,"prevQuarterClose":32.92,"fiveDayClose":34.98,"twentyDayClose":38.37,"sixtyDayClose":28.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"AVLN","fiscalQuarterEnding":"2026/06","expectedEps":-1.03,"name":null,"time":"盘前","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1781928000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVLN","date":"2026-09-18","current":-13.570815,"percent":0.489583,"low":-16.842577,"twenty":-15.433221,"median":-14.265483,"eighty":-13.287874,"high":-8.833116,"avg":-14.368988,"sd":1.265845,"marketCap":1482055365},"quantilePoints":[{"date":"2026-05-01","current":-14.471589,"twenty":-13.343894,"median":-11.652352,"eighty":-9.960811,"marketCap":1233037266},{"date":"2026-05-08","current":-13.215324,"twenty":-14.430368,"median":-13.598092,"eighty":-13.264397,"marketCap":1125998425},{"date":"2026-05-15","current":-15.026112,"twenty":-14.666899,"median":-14.368536,"eighty":-13.42143,"marketCap":1280284879},{"date":"2026-05-22","current":-13.941602,"twenty":-14.643344,"median":-13.941602,"eighty":-13.42143,"marketCap":1187880255},{"date":"2026-05-29","current":-13.931787,"twenty":-14.643344,"median":-13.931787,"eighty":-13.215324,"marketCap":1187044014},{"date":"2026-06-05","current":-13.244767,"twenty":-14.510847,"median":-13.774754,"eighty":-13.102456,"marketCap":1128507148},{"date":"2026-06-12","current":-13.774754,"twenty":-14.471589,"median":-13.774754,"eighty":-13.161343,"marketCap":1173664159},{"date":"2026-06-18","current":-14.383258,"twenty":-14.479441,"median":-13.794383,"eighty":-13.204528,"marketCap":1225511097},{"date":"2026-06-26","current":-13.585419,"twenty":-14.649233,"median":-13.936694,"eighty":-13.238878,"marketCap":1284773093},{"date":"2026-07-02","current":-14.143275,"twenty":-14.655122,"median":-14.03484,"eighty":-13.265378,"marketCap":1337529476},{"date":"2026-07-10","current":-13.557292,"twenty":-14.643344,"median":-13.937009,"eighty":-13.265378,"marketCap":1282113107},{"date":"2026-07-17","current":-12.038425,"twenty":-14.576758,"median":-13.784568,"eighty":-13.15846,"marketCap":1138473879},{"date":"2026-07-24","current":-13.937009,"twenty":-14.519455,"median":-13.774754,"eighty":-13.193732,"marketCap":1318022914},{"date":"2026-07-31","current":-13.740119,"twenty":-14.495144,"median":-13.755125,"eighty":-13.157019,"marketCap":1299403014},{"date":"2026-08-07","current":-15.329303,"twenty":-14.523759,"median":-13.762486,"eighty":-13.165961,"marketCap":1449692206},{"date":"2026-08-14","current":-15.696852,"twenty":-14.725787,"median":-13.774754,"eighty":-13.189862,"marketCap":1621704615},{"date":"2026-08-21","current":-15.932863,"twenty":-15.087944,"median":-13.934398,"eighty":-13.227101,"marketCap":1646087817},{"date":"2026-08-28","current":-15.666815,"twenty":-15.573456,"median":-13.941602,"eighty":-13.249768,"marketCap":1618601298},{"date":"2026-09-04","current":-15.207667,"twenty":-15.433025,"median":-14.088821,"eighty":-13.261019,"marketCap":1571164886},{"date":"2026-09-11","current":-14.877252,"twenty":-15.620135,"median":-14.133223,"eighty":-13.26914,"marketCap":1537028403},{"date":"2026-09-18","current":-14.345155,"twenty":-15.433221,"median":-14.265483,"eighty":-13.287874,"marketCap":1482055365}],"updateTime":1790052009276},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVLN\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1123407353","title":"新闻稿：Avalyn任命Robert J. Meyer医学博士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1123407353","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123407353?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 04:02","pubTimestamp":1789588975,"startTime":"0","endTime":"0","summary":"波士顿，2026年9月16日——Avalyn Pharma Inc.是一家处于临床阶段的生物制药公司，致力于开创吸入式疗法，以变革严重罕见呼吸系统疾病的治疗模式。该公司今日宣布，任命杰出肺病专家、美国食品药品监督管理局前高级领导者RobertJ. Meyer医学博士为其董事会成员。Meyer博士最近曾担任Greenleaf Health药品与生物制品部门负责人。Meyer博士拥有超过25年的领导经验，涵盖监管、学术和行业领域。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LABU","BK4007","AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150445147","title":"Avalyn完成AP01（吸入性吡非尼酮）针对进展性肺纤维化患者的2b期Mist试验目标入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1150445147","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150445147?lang=zh_cn&edition=fundamental","pubTime":"2026-06-17 20:01","pubTimestamp":1781697684,"startTime":"0","endTime":"0","summary":"Avalyn Pharma宣布，其针对进展性肺纤维化患者研发的药物AP01（吸入性吡非尼酮）的2b期Mist临床试验，现已完成目标患者入组工作。这一关键里程碑标志着该试验已进入新的数据收集与分析阶段，为评估该吸入式疗法的有效性与安全性奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVLN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199282092","title":"Avalyn Pharma 将公布AP01（吸入性吡非尼酮）治疗肺纤维化的更多长期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1199282092","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199282092?lang=zh_cn&edition=fundamental","pubTime":"2026-05-21 20:01","pubTimestamp":1779364877,"startTime":"0","endTime":"0","summary":"Avalyn Pharma宣布，关于其吸入性吡非尼酮（AP01）用于治疗肺纤维化的更多长期研究数据，将于2026年欧洲风湿病联盟大会上公布。这些数据有望进一步验证该疗法的长期疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197256686","title":"异动解读 | Avalyn Pharma IPO首日盘中大涨44.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1197256686","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197256686?lang=zh_cn&edition=fundamental","pubTime":"2026-05-01 01:26","pubTimestamp":1777570002,"startTime":"0","endTime":"0","summary":"Avalyn Pharma今日盘中大涨44.44%，引起了市场的广泛关注。消息面上，Avalyn Pharma是一家专注于开发治疗罕见呼吸系统疾病吸入式药物的生物技术公司，其于今日正式在纳斯达克全球精选市场挂牌交易。这两款药物分别为吡非尼酮和尼达尼布的吸入制剂，针对特发性肺纤维化等疾病，旨在提升疗效并减少副作用。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AVLN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AVLN\",params:#limit:6,delay:false,,,undefined,":[]}}